YouTube Facebook LinkedIn Google+ Twitter Xingrss  


COVER STORY
The Drive for the $1000 Genome
The race for next-generation sequencing kicks into gear.

Up Front

IT/Workflow

Clinical Research

In Every Issue 

  • Enabling Technologies
    FIRST BASE - Next-generation sequencing and adaptive trials are both gaining ground, and promise to profoundly impact medicine.
    By Kevin Davies
  • Entelos' First Year as a Public Company
    THE RUSSELL TRANSCRIPT - After going public last year, Entelos released its first financial report as a public company, and reports both gains and losses. 
    By John Russell
  • New Products

For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.